Curative Raises $150 Million in Series B Funding, Achieves Unicorn Valuation to Expand Zero Out-of-Pocket Health Plans

Curative, the Austin, Texas-based health insurance startup that has been rapidly building an alternative to traditional employer health plans, announced a major $150 million Series B funding round that pushes its valuation past the $1.27 billion mark, conferring official unicorn status on the company. The financing will support Curative’s ambitious strategy to expand its innovative $0-out-of-pocket health plan across the United States, bolster technology investments and deepen engagement with both employers and members.

The Series B round was led by Upside Vision Fund, led by TED Chairman Chris Anderson (investor page), reflecting strong conviction in Curative’s unconventional model for delivering and financing healthcare. Alongside the lead, JAM Fund (Justin Mateen’s investment vehicle) played a substantial role in the round, with Mateen personally investing roughly $47.5 million into the company through and alongside his fund. Additional strategic participation came from heavy-hitting backers, including Galaxy Digital and its founder Mike Novogratz (investment firm), Duquesne Family Office (Stanley Druckenmiller’s vehicle), DCVC (Data Collective Venture Capital), and Martin Varsavsky (entrepreneur and investor).

Founded in 2020 by CEO Fred Turner and his co-founders, Curative has grown from a small entrant into a rapidly scaling health plan business trying to reshape how employers buy and employees experience insurance. Its flagship product revolves around a zero out-of-pocket benefit design: members pay no deductibles, copays or coinsurance for covered care as long as they complete a preventive “Baseline Visit” each year, a structure intended to shift incentives toward earlier, preventative care. The company reports measurable results from this model, including a 20 % increase in primary care utilization, a 30 % reduction in hospitalizations and up to 40 % lower prescription drug costs within the first year after employer groups adopt the plan.

According to Curative’s leadership, this capital injection will be put to work across several fronts. A key priority is national expansion; while Curative already offers plans in Texas, Florida and Georgia, the company plans to target deeper growth in Mid-Atlantic states and beyond, strengthening its financial reserves to meet state regulatory requirements as part of that push. The funding will also accelerate development of Curative’s AI-driven member service platform, improve its preventative health engagement capabilities, and enhance the reach of its Curative Cash Card—a mechanism that pays providers instantly at the point of care and extends access to over a million providers nationwide without legacy network constraints.

In addition to growth, the funding validates investor confidence in Curative’s unorthodox strategy for tackling the entrenched challenges of employer-sponsored healthcare. Many traditional plans and insurers have been criticized for complexity, surprise billing and misaligned incentives that emphasize claims volume over long-term health outcomes. Curative’s approach is designed to simplify member experiences while aligning plan design with preventative care and cost transparency.

Despite being less than three years old, Curative claims profitability and reports serving more than 1,200 employer clients and over 165,000 members—milestones that set it apart from many high-valuation startups that remain unprofitable long past their initial funding rounds. The company’s management and investors have framed these metrics as evidence of market demand for its product and validation of its fundamentals.

The broader insurtech sector has faced headwinds in recent years, with overall funding down and venture capital focusing on niche areas such as artificial intelligence and digital infrastructure. Within that context, Curative’s sizable Series B raise underscores continued venture interest in healthcare innovations aimed at disrupting legacy systems.

Curative’s newest funding represents one of the most significant infusions of venture capital in the health insurance startup space recently, and positions the company to scale its preventative, tech-driven approach to employer health coverage nationwide. Investors and management alike have highlighted the company’s potential to reshape elements of the broader healthcare landscape if it can maintain growth while delivering better health outcomes and cost management for members.